🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to determine the efficacy and safety of durvalumab a...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-12-27
Trial ID
NCT03819465
MARIO-3 is a Phase 2 multi-arm combination cohort study designed to evaluat...
Status
Unknown
Location
Ironwood Cancer and Research Center
Start Date
2019-12-17
Trial ID
NCT03961698
Treatments Being Tested
This is a study consisting of four cohorts in this setting. In Cohort 1, th...
Status
Completed
Location
Pacific Shores Medical Group
Start Date
2018-02-13
Trial ID
NCT03800836
Treatments Being Tested
The purpose of this study is to learn about the safety and effects of the s...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2024-12-10
Trial ID
NCT06704724
This is a prospective, multicenter, randomized, open-label, umbrella superi...
Status
Not Yet Recruiting
Location
Sub-i
Start Date
2026-07-07
Trial ID
NCT07709533
Background: LMB-100 is a man-made protein designed to kill cancer cells. L...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2016-08-03
Trial ID
NCT02810418
Treatments Being Tested
This is a Phase II, open-label, randomized controlled umbrella trial evalua...
Status
Unknown
Location
Cancer Hospital Affiliated to Fudan University
Start Date
2020-07-28
Trial ID
NCT04395989
Treatments Being Tested
The purpose of this study is to learn about the safety and effects of the s...
Status
Active Not Recruiting
Location
Highlands Oncology Group, PA
Start Date
2024-06-27
Trial ID
NCT06447662
This is a phase 1, non-randomized open-label, multicenter platform study de...
Status
Recruiting
Location
A site selected by Taiho Pharmaceutical Co., Ltd.
Start Date
2021-06-01
Trial ID
NCT04999761
Background: LMB-100 is a man-made protein. It is attracted to the mesothel...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2016-07-27
Trial ID
NCT02798536
Treatments Being Tested